← Eichor
Condition: Cancer Associated Thrombosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cancer Associated Thrombosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
Phase N/A · 1 location(s) · Hanneke W. M. van Laarhoven · NCT06519292Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT07399977Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Phase 2 · 3 location(s) · University of Colorado, Denver · NCT05969496A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07549477Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevan
Phase N/A · 1 location(s) · Ottawa Hospital Research Institute · NCT06894576Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
NA · 4 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06386107Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Phase N/A · 48 location(s) · Fundación Sociedad Española de Oncologia Médica · NCT03855592Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT
Phase 2 · 1 location(s) · Yongyi Zeng · NCT06349317TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
Phase 2 · 1 location(s) · Fei Gao · NCT06646198The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06284343Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Canc
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07493304STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Phase 4 · 4 location(s) · Tzu-Fei Wang · NCT05255003Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06714734Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07210671Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
NA · 1 location(s) · Medical University of Gdansk · NCT07270263TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Ph
Phase 2 · 1 location(s) · Fei Gao · NCT05882370The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Phase 3 · 3 location(s) · Quercis Pharma AG · NCT06861088Statins to Prevent Cancer Associated Blood Clots
Phase 4 · 2 location(s) · Brigham and Women's Hospital · NCT07303816REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Phase 3 · 13 location(s) · Regeneron Pharmaceuticals · NCT07410117
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.